CARLEY ANDERSON: Open Payments
NPI 1275158305 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 29 payments from 9 companies in 2025. Trend: 2023 $543 · 2024 $575 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $276 |
| AstraZeneca Pharmaceuticals LP | 9 | $195 |
| Edwards Lifesciences Corporation | 1 | $173 |
| Boston Scientific Corporation | 1 | $142 |
| Novo Nordisk Inc | 5 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Hologic Sales and Service, LLC | 2 | $52 |
| Amgen Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $46 |
Products named: SAPIEN 3 Ultra RESILIA, FARAPULSE, CREON, LINZESS, AIRSUPRA, BREZTRI, XIFAXAN, APTIMA.
Industry payments across CA — which companies pay providers there.
